Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 95

1.

No Association between the Mitochondrial Genome and Prostate Cancer Risk: The Multiethnic Cohort.

Giorgi EE, Li Y, Caberto CP, Beckman KB, Lum-Jones A, Haiman CA, Le Marchand L, Stram DO, Saxena R, Cheng I.

Cancer Epidemiol Biomarkers Prev. 2016 Jun;25(6):1001-3. doi: 10.1158/1055-9965.EPI-16-0111. Epub 2016 Mar 28.

2.

Association of Genes, Pathways, and Haplogroups of the Mitochondrial Genome with the Risk of Colorectal Cancer: The Multiethnic Cohort.

Li Y, Beckman KB, Caberto C, Kazma R, Lum-Jones A, Haiman CA, Le Marchand L, Stram DO, Saxena R, Cheng I.

PLoS One. 2015 Sep 4;10(9):e0136796. doi: 10.1371/journal.pone.0136796. eCollection 2015.

3.

Haplotype-based association studies of IGFBP1 and IGFBP3 with prostate and breast cancer risk: the multiethnic cohort.

Cheng I, Penney KL, Stram DO, Le Marchand L, Giorgi E, Haiman CA, Kolonel LN, Pike M, Hirschhorn J, Henderson BE, Freedman ML.

Cancer Epidemiol Biomarkers Prev. 2006 Oct;15(10):1993-7.

4.

Fine-mapping IGF1 and prostate cancer risk in African Americans: the multiethnic cohort study.

Giorgi EE, Stram DO, Taverna D, Turner SD, Schumacher F, Haiman CA, Lum-Jones A, Tirikainen M, Caberto C, Duggan D, Henderson BE, Le Marchand L, Cheng I.

Cancer Epidemiol Biomarkers Prev. 2014 Sep;23(9):1928-32. doi: 10.1158/1055-9965.EPI-14-0333. Epub 2014 Jun 5.

5.

Generalizability of associations from prostate cancer genome-wide association studies in multiple populations.

Waters KM, Le Marchand L, Kolonel LN, Monroe KR, Stram DO, Henderson BE, Haiman CA.

Cancer Epidemiol Biomarkers Prev. 2009 Apr;18(4):1285-9. doi: 10.1158/1055-9965.EPI-08-1142. Epub 2009 Mar 24.

6.

Evaluating genetic risk for prostate cancer among Japanese and Latinos.

Cheng I, Chen GK, Nakagawa H, He J, Wan P, Laurie CC, Shen J, Sheng X, Pooler LC, Crenshaw AT, Mirel DB, Takahashi A, Kubo M, Nakamura Y, Al Olama AA, Benlloch S, Donovan JL, Guy M, Hamdy FC, Kote-Jarai Z, Neal DE, Wilkens LR, Monroe KR, Stram DO, Muir K, Eeles RA, Easton DF, Kolonel LN, Henderson BE, Le Marchand L, Haiman CA.

Cancer Epidemiol Biomarkers Prev. 2012 Nov;21(11):2048-58. doi: 10.1158/1055-9965.EPI-12-0598. Epub 2012 Aug 24.

7.

Genome-wide testing of putative functional exonic variants in relationship with breast and prostate cancer risk in a multiethnic population.

Haiman CA, Han Y, Feng Y, Xia L, Hsu C, Sheng X, Pooler LC, Patel Y, Kolonel LN, Carter E, Park K, Le Marchand L, Van Den Berg D, Henderson BE, Stram DO.

PLoS Genet. 2013 Mar;9(3):e1003419. doi: 10.1371/journal.pgen.1003419. Epub 2013 Mar 28.

8.

Screening and association testing of common coding variation in steroid hormone receptor co-activator and co-repressor genes in relation to breast cancer risk: the Multiethnic Cohort.

Haiman CA, Garcia RR, Hsu C, Xia L, Ha H, Sheng X, Le Marchand L, Kolonel LN, Henderson BE, Stallcup MR, Greene GL, Press MF.

BMC Cancer. 2009 Jan 30;9:43. doi: 10.1186/1471-2407-9-43.

9.

Common genetic variation in IGF1 and prostate cancer risk in the Multiethnic Cohort.

Cheng I, Stram DO, Penney KL, Pike M, Le Marchand L, Kolonel LN, Hirschhorn J, Altshuler D, Henderson BE, Freedman ML.

J Natl Cancer Inst. 2006 Jan 18;98(2):123-34.

PMID:
16418515
10.

A comprehensive analysis of common genetic variation in prolactin (PRL) and PRL receptor (PRLR) genes in relation to plasma prolactin levels and breast cancer risk: the multiethnic cohort.

Lee SA, Haiman CA, Burtt NP, Pooler LC, Cheng I, Kolonel LN, Pike MC, Altshuler D, Hirschhorn JN, Henderson BE, Stram DO.

BMC Med Genet. 2007 Dec 1;8:72.

11.

Serum zinc and prostate cancer risk in a nested case-control study: The multiethnic cohort.

Park SY, Wilkens LR, Morris JS, Henderson BE, Kolonel LN.

Prostate. 2013 Feb 15;73(3):261-6. doi: 10.1002/pros.22565. Epub 2012 Jul 31.

12.

Replication and heritability of prostate cancer risk variants: impact of population-specific factors.

Virlogeux V, Graff RE, Hoffmann TJ, Witte JS.

Cancer Epidemiol Biomarkers Prev. 2015 Jun;24(6):938-43. doi: 10.1158/1055-9965.EPI-14-1372. Epub 2015 Mar 25.

13.

Associations between RNA splicing regulatory variants of stemness-related genes and racial disparities in susceptibility to prostate cancer.

Wang Y, Freedman JA, Liu H, Moorman PG, Hyslop T, George DJ, Lee NH, Patierno SR, Wei Q.

Int J Cancer. 2017 Aug 15;141(4):731-743. doi: 10.1002/ijc.30787. Epub 2017 Jun 1.

14.

Genetic variation in the HSD17B1 gene and risk of prostate cancer.

Kraft P, Pharoah P, Chanock SJ, Albanes D, Kolonel LN, Hayes RB, Altshuler D, Andriole G, Berg C, Boeing H, Burtt NP, Bueno-de-Mesquita B, Calle EE, Cann H, Canzian F, Chen YC, Crawford DE, Dunning AM, Feigelson HS, Freedman ML, Gaziano JM, Giovannucci E, Gonzalez CA, Haiman CA, Hallmans G, Henderson BE, Hirschhorn JN, Hunter DJ, Kaaks R, Key T, Le Marchand L, Ma J, Overvad K, Palli D, Pike MC, Riboli E, Rodriguez C, Setiawan WV, Stampfer MJ, Stram DO, Thomas G, Thun MJ, Travis R, Trichopoulou A, Virtamo J, Wacholder S.

PLoS Genet. 2005 Nov;1(5):e68. Epub 2005 Nov 25.

15.

Fine-mapping of IL16 gene and prostate cancer risk in African Americans.

Batai K, Shah E, Murphy AB, Newsome J, Ruden M, Ahaghotu C, Kittles RA.

Cancer Epidemiol Biomarkers Prev. 2012 Nov;21(11):2059-68. doi: 10.1158/1055-9965.EPI-12-0707. Epub 2012 Aug 24.

16.

Common genetic variation at PTEN and risk of sporadic breast and prostate cancer.

Haiman CA, Stram DO, Cheng I, Giorgi EE, Pooler L, Penney K, Le Marchand L, Henderson BE, Freedman ML.

Cancer Epidemiol Biomarkers Prev. 2006 May;15(5):1021-5.

17.

A large multiethnic genome-wide association study of prostate cancer identifies novel risk variants and substantial ethnic differences.

Hoffmann TJ, Van Den Eeden SK, Sakoda LC, Jorgenson E, Habel LA, Graff RE, Passarelli MN, Cario CL, Emami NC, Chao CR, Ghai NR, Shan J, Ranatunga DK, Quesenberry CP, Aaronson D, Presti J, Wang Z, Berndt SI, Chanock SJ, McDonnell SK, French AJ, Schaid DJ, Thibodeau SN, Li Q, Freedman ML, Penney KL, Mucci LA, Haiman CA, Henderson BE, Seminara D, Kvale MN, Kwok PY, Schaefer C, Risch N, Witte JS.

Cancer Discov. 2015 Aug;5(8):878-91. doi: 10.1158/2159-8290.CD-15-0315. Epub 2015 Jun 1.

18.

No association between the SRD5A2 gene A49T missense variant and prostate cancer risk: lessons learned.

Pearce CL, Van Den Berg DJ, Makridakis N, Reichardt JK, Ross RK, Pike MC, Kolonel LN, Henderson BE.

Hum Mol Genet. 2008 Aug 15;17(16):2456-61. doi: 10.1093/hmg/ddn145. Epub 2008 May 10.

19.

Association of mis-sense substitution in SRD5A2 gene with prostate cancer in African-American and Hispanic men in Los Angeles, USA.

Makridakis NM, Ross RK, Pike MC, Crocitto LE, Kolonel LN, Pearce CL, Henderson BE, Reichardt JK.

Lancet. 1999 Sep 18;354(9183):975-8.

PMID:
10501358
20.

Circulating fatty acids and prostate cancer risk in a nested case-control study: the Multiethnic Cohort.

Park SY, Wilkens LR, Henning SM, Le Marchand L, Gao K, Goodman MT, Murphy SP, Henderson BE, Kolonel LN.

Cancer Causes Control. 2009 Mar;20(2):211-23. doi: 10.1007/s10552-008-9236-4. Epub 2008 Sep 27.

Supplemental Content

Support Center